Craig Collard - Chief Executive Officer, Director at Heron Therapeutics, Inc. /De/

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
HRTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Craig Collard since 12/1/2024

Holdings reported by Craig Collard for Heron Therapeutics, Inc. /De/

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 523K $659K $1.26 Oct 31, 2025 Direct
Restricted Stock Units 452K $330K $2.64 Oct 31, 2025 Direct Common Stock
Employee Stock Option (Right to Buy) 1.11M Jan 31, 2025 Direct Common Stock

Transactions reported by Craig Collard for Heron Therapeutics, Inc. /De/

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.